Together, these findings suggest that although TRAIL is present in soluble form in IPF, there is a lack of TRAIL+ myeloid cells in IPF lung samples and IPF fibroblasts lack DR5 expression, presumably due, in part, to the inhibitory effects of IL-13. The gene discussed is IL13; the disease is idiopathic pulmonary fibrosis.